Skip to content
Screener

Cytokinetics CYTK Price / book

Price / book at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
5.3×-0.2×
Eli Lilly logo
Eli LillyLLY
31.6×-6.7×
Merck & Co. logo
Merck & Co.MRK
7.6×+3.5×
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
6.1×+3.9×
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
6.9×+2.0×
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
6.3×+2.9×

Other financials

Income statement

See full
Revenue$28.6M-57.1%
Operating income-$179.2M-60.7%
Net income-$198.8M-47.9%
EPS (diluted)-$1.50-33.9%

Balance sheet

See full
Cash & equivalents$255.3M+241%
Total debt$399.0M+31.2%
Total equity-$173.5M+52.9%
Total assets$1.9B+57.0%

Cash flow

See full
Operating cash flow-$159.8M-24.6%
CapEx$4.3M+4.6%
Free cash flow-$164.2M-24.0%

Valuation

See full
Market cap$11.05B+163%
Enterprise value$11.19B+153%
P/S163.3×+114×

Profitability

See full
Operating margin-1,046.1%+1,858pp
Net margin-1,321.1%+8,702pp
FCF margin-858.2%+1,799pp

Returns & leverage

See full
Return on equity-337.6%—
Debt / equity2.2×—
Current ratio6.7×-0.1×

Where this comes from

Calculated from Cytokinetics’s reported figures.

market cap/total stockholders equity=58.5×

Based on the most recent quarter.

The source filing: Cytokinetics’s 10-Q, filed August 9, 2024. Open the filing →

Filed
Aug 9, 2024
Fiscal quarter
Q2 FY2024
Calendar quarter
Q2 2024
Accession
0000950170-24-094743

FAQ

What is Cytokinetics's price / book?
Cytokinetics (CYTK) reported price / book of 58.5× in Q2 2024.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Cytokinetics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude